Skip to content
Lower risk Medical device recall · FDA · Published November 18, 2022

Ventana PD-L1 (SP142) Assay Recall: Light Staining May Cause False-Negative Results

Ventana Medical Systems recalls PD-L1 (SP142) assays due to light staining causing potential false-negative results in cancer testing. Affected units have specific UDI-DI codes.

🇺🇸 FDA recall #Z-0907-2023Medical deviceVentana ›
Take action

Contact the company

Recalling firmVentana Medical Systems, Inc.1910 E Innovation Park Dr · Oro Valley, AZ 85755-1962
✎ GovInfoNow plain-language explainer

Ventana Medical Systems has recalled certain PD-L1 (SP142) cancer testing assays because light staining can lead to false-negative results. This means the test might incorrectly show a negative result when the patient actually has cancer, potentially delaying treatment. Read more at govinfonow.com/recall/59316-ventana-pd-l1-sp142-assay-recall-light-staining-may-cause.

Source Summary by GovInfoNow · govinfonow.com/recall/59316-ventana-pd-l1-sp142-assay-recall-light-staining-may-cause · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0907-2023

Cite this page

“Ventana PD-L1 (SP142) Assay Recall: Light Staining May Cause False-Negative Results.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59316-ventana-pd-l1-sp142-assay-recall-light-staining-may-cause. Based on FDA recall #Z-0907-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0907-2023%22&limit=1).

The FDA announced on 2022-11-18 that Ventana Medical Systems, Inc. is recalling VENTANA PD-L1 (SP142) Assays due to light staining that may cause false-negative results. The recall affects 8,927 kits distributed worldwide.

How to tell if you have it

  • Brand: Ventana
  • Product: VENTANA PD-L1 (SP142) Assay (Class III, US IVD) 07709374001
  • Product: VENTANA PD-L1 (SP142) Assay (CE IVD Predictive) 08008540001
  • Product: VENTANA PD-L1 (SP142) IHC Assay (CE IVD Analytical) 07011571001
  • UDI-DI Code: 04015630967155
  • Lot codes: F30596, G27114, G31438, H03958, H13049, H35110, J12769, J18775, J25361
  • UDI-DI Code: 07613336106709
  • Lot codes: F31427, G06715, G16831, G24564, H00001, H07164, H15132, H18578, J00572, J01568, J14244, J20989
  • Lot codes: H08373
  • UDI-DI Code: 04015630976591
  • Lot codes: H17865, H30521, H35111, J11932, J20132

The hazard

Internal comparison studies revealed unacceptable light staining that affects the borderline of positive versus negative test results. This reduction in staining intensity and percent positivity could potentially lead to a false-negative PD-L1 result.

Context

GovInfoNow's records show Ventana Medical Systems, Inc. has 7 other recalls on record since 2017-12-19. Other recent recalls of similar products include Ventana navify Digital Pathology v2.5 Software Image Discrepancy Recall (2026-04-20), Ventana anti-CD10 antibody recall (2024-06-27), and Ventana HE : Fluid Leak Risk Could Cause Fire in Lab Equipment (2022-06-01). Other recent recalls of similar products include Hologic Aptima HPV Assay Kit Recall (2026-02-18), Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (2026-07-13), and Diagnostica Stago Asserachrom HPIA Kit Recall (2025-12-15).

How to tell if you have this one

Check for the UDI-DI codes: 04015630967155, 07613336106709, or 04015630976591 on the product packaging. The product names include VENTANA PD-L1 (SP142) Assay (Class III, US IVD) or similar.

  • Brand
    Ventana
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for UDI-DI codes 04015630967155, 07613336106709, or 04015630976591 on the product packaging.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 34 states.

Alaska: nationwideAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: nationwideMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - U.S. Nationwide distribution including in the states of AL, AZ, CA, CO,CT, DC, DE, FL, GA, IL, IN, KS, KY, MA, MD, MI, MN, NC, ND, NE, NJ, NM, NV, NY, OH, OR, PA, Puerto Rico, SC, TN, TX, UT, VA, VT, WA, and WI.…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Puerto Rico, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Nov 18, 202212. FDA classified it Class II: Jan 6, 202323. Published in FDA’s Enforcement Report: Jan 18, 2023320222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0907-2023 (November 18, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0907-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA